Advani R - Search Results

1

The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.

Visani G, Gamberi B, Greenberg P, Advani R, Gulati S, Champlin R, Hoglund M, Karanes C, Williams S, Keating A, et al. Visani G, et al. Among authors: advani r. Bone Marrow Transplant. 1991;7 Suppl 2:81. Bone Marrow Transplant. 1991. PMID: 1878732 Clinical Trial. No abstract available.

2

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.

Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, Lamborn KR, Fleming NC, Bonnem EM, Greenberg PL. Advani R, et al. Ann Intern Med. 1992 Feb 1;116(3):183-9. doi: 10.7326/0003-4819-116-3-183. Ann Intern Med. 1992. PMID: 1345803 Clinical Trial.

3

Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Chao NJ, Berry GJ, Advani R, Horning SJ, Weiss LM, Blume KG. Chao NJ, et al. Among authors: advani r. Transplantation. 1993 Jun;55(6):1425-8. Transplantation. 1993. PMID: 8390736 No abstract available.

4

GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.

Greenberg P, Advani R, Keating A, Gulati SC, Nimer S, Champlin R, Karanes C, Gorin NC, Powles RL, Smith A, Lamborn K, Cuffie C. Greenberg P, et al. Among authors: advani r. Bone Marrow Transplant. 1996 Dec;18(6):1057-64. Bone Marrow Transplant. 1996. PMID: 8971373 Clinical Trial.

5

Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar).

Advani R, Saba HI, Tallman MS, Rowe JM, Wiernik PH, Ramek J, Dugan K, Lum B, Villena J, Davis E, Paietta E, Litchman M, Sikic BI, Greenberg PL. Advani R, et al. Blood. 1999 Feb 1;93(3):787-95. Blood. 1999. PMID: 9920827 Free article. Clinical Trial.

6

Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC).

Advani R, Visani G, Milligan D, Saba H, Tallman M, Rowe JM, Wiernik PH, Ramek J, Dugan K, Lum B, Villena J, Davis E, Paietta E, Litchman M, Covelli A, Sikic B, Greenberg P. Advani R, et al. Adv Exp Med Biol. 1999;457:47-56. doi: 10.1007/978-1-4615-4811-9_6. Adv Exp Med Biol. 1999. PMID: 10500779 Clinical Trial.

7

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

Greenberg PL, Lee SJ, Advani R, Tallman MS, Sikic BI, Letendre L, Dugan K, Lum B, Chin DL, Dewald G, Paietta E, Bennett JM, Rowe JM. Greenberg PL, et al. Among authors: advani r. J Clin Oncol. 2004 Mar 15;22(6):1078-86. doi: 10.1200/JCO.2004.07.048. J Clin Oncol. 2004. PMID: 15020609 Free PMC article. Clinical Trial.

8

Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.

Koontz MZ, Horning SJ, Balise R, Greenberg PL, Rosenberg SA, Hoppe RT, Advani RH. Koontz MZ, et al. Among authors: advani rh. J Clin Oncol. 2013 Feb 10;31(5):592-8. doi: 10.1200/JCO.2012.44.5791. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295809 Free PMC article.

9

Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory Hodgkin lymphoma: twenty years experience at a single institution.

Garfin PM, Link MP, Donaldson SS, Advani RH, Luna-Fineman S, Kharbanda S, Porteus M, Weinberg KI, Agarwal-Hashmi R. Garfin PM, et al. Among authors: advani rh. Biol Blood Marrow Transplant. 2015 Feb;21(2):326-34. doi: 10.1016/j.bbmt.2014.10.020. Epub 2014 Oct 29. Biol Blood Marrow Transplant. 2015. PMID: 25445024 Free article.

10

Outcomes of adults with lymphoma treated with nonmyeloablative TLI-ATG and radiation boost to high risk or residual disease before allogeneic hematopoietic cell transplant.

Dworkin ML, Jiang AL, Von Eyben R, Spinner MA, Advani RH, Lowsky R, Hiniker SM, Hoppe RT. Dworkin ML, et al. Among authors: advani rh. Bone Marrow Transplant. 2022 Jan;57(1):106-112. doi: 10.1038/s41409-021-01495-4. Epub 2021 Oct 20. Bone Marrow Transplant. 2022. PMID: 34671121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters